The efficacy and safety of mirogabalin for tha chemotherapy induced peripheral neuropathy patients in Gemcitabine+nab-Paclitaxel therapy
Not Applicable
- Conditions
- Chemotherapy induced peripheraly neuropathy
- Registration Number
- JPRN-UMIN000038742
- Lead Sponsor
- Juntendo University
- Brief Summary
Increased numbness and tingling severity(1.84 vs 1.76; P=0.63)and interference(1.42 vs 1.44; P=0.80)were not seen in any of the 25 enrolled patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1 The patients who could not write questionnaire. 2 The patients who were ineligible.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method